Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review
• Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol re...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Mistarz, Nicolaj [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
19 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain - Ohashi, Nobuko ELSEVIER, 2022, official journal of the International Behavioral Neuroscience Society, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:125 ; year:2021 ; pages:608-626 ; extent:19 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.neubiorev.2021.02.038 |
|---|
| Katalog-ID: |
ELV053864158 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV053864158 | ||
| 003 | DE-627 | ||
| 005 | 20230624202602.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.neubiorev.2021.02.038 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica |
| 035 | |a (DE-627)ELV053864158 | ||
| 035 | |a (ELSEVIER)S0149-7634(21)00098-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Mistarz, Nicolaj |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review |
| 264 | 1 | |c 2021 | |
| 300 | |a 19 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. | ||
| 650 | 7 | |a Non-affective cognition |2 Elsevier | |
| 650 | 7 | |a Alcohol use disorder |2 Elsevier | |
| 650 | 7 | |a Alcohol amnestic disorder |2 Elsevier | |
| 650 | 7 | |a Korsakoff psychosis |2 Elsevier | |
| 650 | 7 | |a Nootropics |2 Elsevier | |
| 650 | 7 | |a Pharmacotherapy |2 Elsevier | |
| 650 | 7 | |a Alcohol dependence |2 Elsevier | |
| 650 | 7 | |a Alcoholic organic brain syndrome |2 Elsevier | |
| 650 | 7 | |a Cognitive enhancers |2 Elsevier | |
| 650 | 7 | |a Alcohol related dementia |2 Elsevier | |
| 650 | 7 | |a Neurocognition |2 Elsevier | |
| 650 | 7 | |a Cognitive deficits |2 Elsevier | |
| 700 | 1 | |a Andersen, Kjeld |4 oth | |
| 700 | 1 | |a Nielsen, Anette Søgaard |4 oth | |
| 700 | 1 | |a Goudriaan, Anneke E. |4 oth | |
| 700 | 1 | |a Michel, Tanja Maria |4 oth | |
| 700 | 1 | |a Skøt, Lotte |4 oth | |
| 700 | 1 | |a Nielsen, Dorthe Grüner |4 oth | |
| 700 | 1 | |a Mellentin, Angelina Isabella |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Ohashi, Nobuko ELSEVIER |t Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain |d 2022 |d official journal of the International Behavioral Neuroscience Society |g Amsterdam [u.a.] |w (DE-627)ELV007772211 |
| 773 | 1 | 8 | |g volume:125 |g year:2021 |g pages:608-626 |g extent:19 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.neubiorev.2021.02.038 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.90 |j Neurologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 125 |j 2021 |h 608-626 |g 19 | ||
| author_variant |
n m nm |
|---|---|
| matchkey_str |
mistarznicolajandersenkjeldnielsenanette:2021----:hraooiaehniggnsagtncgiinnainsihlooidcdercgi |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.90 |
| publishDate |
2021 |
| allfields |
10.1016/j.neubiorev.2021.02.038 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV053864158 (ELSEVIER)S0149-7634(21)00098-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.90 bkl Mistarz, Nicolaj verfasserin aut Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review 2021 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Elsevier Andersen, Kjeld oth Nielsen, Anette Søgaard oth Goudriaan, Anneke E. oth Michel, Tanja Maria oth Skøt, Lotte oth Nielsen, Dorthe Grüner oth Mellentin, Angelina Isabella oth Enthalten in Elsevier Science Ohashi, Nobuko ELSEVIER Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain 2022 official journal of the International Behavioral Neuroscience Society Amsterdam [u.a.] (DE-627)ELV007772211 volume:125 year:2021 pages:608-626 extent:19 https://doi.org/10.1016/j.neubiorev.2021.02.038 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.90 Neurologie VZ AR 125 2021 608-626 19 |
| spelling |
10.1016/j.neubiorev.2021.02.038 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV053864158 (ELSEVIER)S0149-7634(21)00098-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.90 bkl Mistarz, Nicolaj verfasserin aut Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review 2021 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Elsevier Andersen, Kjeld oth Nielsen, Anette Søgaard oth Goudriaan, Anneke E. oth Michel, Tanja Maria oth Skøt, Lotte oth Nielsen, Dorthe Grüner oth Mellentin, Angelina Isabella oth Enthalten in Elsevier Science Ohashi, Nobuko ELSEVIER Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain 2022 official journal of the International Behavioral Neuroscience Society Amsterdam [u.a.] (DE-627)ELV007772211 volume:125 year:2021 pages:608-626 extent:19 https://doi.org/10.1016/j.neubiorev.2021.02.038 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.90 Neurologie VZ AR 125 2021 608-626 19 |
| allfields_unstemmed |
10.1016/j.neubiorev.2021.02.038 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV053864158 (ELSEVIER)S0149-7634(21)00098-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.90 bkl Mistarz, Nicolaj verfasserin aut Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review 2021 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Elsevier Andersen, Kjeld oth Nielsen, Anette Søgaard oth Goudriaan, Anneke E. oth Michel, Tanja Maria oth Skøt, Lotte oth Nielsen, Dorthe Grüner oth Mellentin, Angelina Isabella oth Enthalten in Elsevier Science Ohashi, Nobuko ELSEVIER Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain 2022 official journal of the International Behavioral Neuroscience Society Amsterdam [u.a.] (DE-627)ELV007772211 volume:125 year:2021 pages:608-626 extent:19 https://doi.org/10.1016/j.neubiorev.2021.02.038 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.90 Neurologie VZ AR 125 2021 608-626 19 |
| allfieldsGer |
10.1016/j.neubiorev.2021.02.038 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV053864158 (ELSEVIER)S0149-7634(21)00098-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.90 bkl Mistarz, Nicolaj verfasserin aut Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review 2021 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Elsevier Andersen, Kjeld oth Nielsen, Anette Søgaard oth Goudriaan, Anneke E. oth Michel, Tanja Maria oth Skøt, Lotte oth Nielsen, Dorthe Grüner oth Mellentin, Angelina Isabella oth Enthalten in Elsevier Science Ohashi, Nobuko ELSEVIER Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain 2022 official journal of the International Behavioral Neuroscience Society Amsterdam [u.a.] (DE-627)ELV007772211 volume:125 year:2021 pages:608-626 extent:19 https://doi.org/10.1016/j.neubiorev.2021.02.038 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.90 Neurologie VZ AR 125 2021 608-626 19 |
| allfieldsSound |
10.1016/j.neubiorev.2021.02.038 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV053864158 (ELSEVIER)S0149-7634(21)00098-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.90 bkl Mistarz, Nicolaj verfasserin aut Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review 2021 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Elsevier Andersen, Kjeld oth Nielsen, Anette Søgaard oth Goudriaan, Anneke E. oth Michel, Tanja Maria oth Skøt, Lotte oth Nielsen, Dorthe Grüner oth Mellentin, Angelina Isabella oth Enthalten in Elsevier Science Ohashi, Nobuko ELSEVIER Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain 2022 official journal of the International Behavioral Neuroscience Society Amsterdam [u.a.] (DE-627)ELV007772211 volume:125 year:2021 pages:608-626 extent:19 https://doi.org/10.1016/j.neubiorev.2021.02.038 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.90 Neurologie VZ AR 125 2021 608-626 19 |
| language |
English |
| source |
Enthalten in Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain Amsterdam [u.a.] volume:125 year:2021 pages:608-626 extent:19 |
| sourceStr |
Enthalten in Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain Amsterdam [u.a.] volume:125 year:2021 pages:608-626 extent:19 |
| format_phy_str_mv |
Article |
| bklname |
Neurologie |
| institution |
findex.gbv.de |
| topic_facet |
Non-affective cognition Alcohol use disorder Alcohol amnestic disorder Korsakoff psychosis Nootropics Pharmacotherapy Alcohol dependence Alcoholic organic brain syndrome Cognitive enhancers Alcohol related dementia Neurocognition Cognitive deficits |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain |
| authorswithroles_txt_mv |
Mistarz, Nicolaj @@aut@@ Andersen, Kjeld @@oth@@ Nielsen, Anette Søgaard @@oth@@ Goudriaan, Anneke E. @@oth@@ Michel, Tanja Maria @@oth@@ Skøt, Lotte @@oth@@ Nielsen, Dorthe Grüner @@oth@@ Mellentin, Angelina Isabella @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007772211 |
| dewey-sort |
3610 |
| id |
ELV053864158 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053864158</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624202602.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.neubiorev.2021.02.038</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053864158</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0149-7634(21)00098-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mistarz, Nicolaj</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">19</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-affective cognition</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol amnestic disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Korsakoff psychosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nootropics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol dependence</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcoholic organic brain syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive enhancers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol related dementia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neurocognition</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive deficits</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andersen, Kjeld</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, Anette Søgaard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goudriaan, Anneke E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Michel, Tanja Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Skøt, Lotte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, Dorthe Grüner</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mellentin, Angelina Isabella</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Ohashi, Nobuko ELSEVIER</subfield><subfield code="t">Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the International Behavioral Neuroscience Society</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007772211</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:125</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:608-626</subfield><subfield code="g">extent:19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.neubiorev.2021.02.038</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.90</subfield><subfield code="j">Neurologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">125</subfield><subfield code="j">2021</subfield><subfield code="h">608-626</subfield><subfield code="g">19</subfield></datafield></record></collection>
|
| author |
Mistarz, Nicolaj |
| spellingShingle |
Mistarz, Nicolaj ddc 610 bkl 44.90 Elsevier Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review |
| authorStr |
Mistarz, Nicolaj |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007772211 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.90 bkl Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits Elsevier |
| topic |
ddc 610 bkl 44.90 Elsevier Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits |
| topic_unstemmed |
ddc 610 bkl 44.90 Elsevier Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits |
| topic_browse |
ddc 610 bkl 44.90 Elsevier Non-affective cognition Elsevier Alcohol use disorder Elsevier Alcohol amnestic disorder Elsevier Korsakoff psychosis Elsevier Nootropics Elsevier Pharmacotherapy Elsevier Alcohol dependence Elsevier Alcoholic organic brain syndrome Elsevier Cognitive enhancers Elsevier Alcohol related dementia Elsevier Neurocognition Elsevier Cognitive deficits |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
k a ka a s n as asn a e g ae aeg t m m tm tmm l s ls d g n dg dgn a i m ai aim |
| hierarchy_parent_title |
Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain |
| hierarchy_parent_id |
ELV007772211 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007772211 |
| title |
Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review |
| ctrlnum |
(DE-627)ELV053864158 (ELSEVIER)S0149-7634(21)00098-1 |
| title_full |
Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review |
| author_sort |
Mistarz, Nicolaj |
| journal |
Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain |
| journalStr |
Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
608 |
| author_browse |
Mistarz, Nicolaj |
| container_volume |
125 |
| physical |
19 |
| class |
610 VZ 44.90 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Mistarz, Nicolaj |
| doi_str_mv |
10.1016/j.neubiorev.2021.02.038 |
| dewey-full |
610 |
| title_sort |
pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: a systematic review |
| title_auth |
Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review |
| abstract |
• Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. |
| abstractGer |
• Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. |
| abstract_unstemmed |
• Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review |
| url |
https://doi.org/10.1016/j.neubiorev.2021.02.038 |
| remote_bool |
true |
| author2 |
Andersen, Kjeld Nielsen, Anette Søgaard Goudriaan, Anneke E. Michel, Tanja Maria Skøt, Lotte Nielsen, Dorthe Grüner Mellentin, Angelina Isabella |
| author2Str |
Andersen, Kjeld Nielsen, Anette Søgaard Goudriaan, Anneke E. Michel, Tanja Maria Skøt, Lotte Nielsen, Dorthe Grüner Mellentin, Angelina Isabella |
| ppnlink |
ELV007772211 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.neubiorev.2021.02.038 |
| up_date |
2024-07-06T20:08:14.565Z |
| _version_ |
1803861617086038016 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053864158</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624202602.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.neubiorev.2021.02.038</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053864158</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0149-7634(21)00098-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mistarz, Nicolaj</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">19</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Little is known about “cognitive enhancers” in alcohol-related disorders. • Previous reviews have focused on patients with more severe neurocognitive deficits. • Preliminary evidence suggests modafinil as a putative transdiagnostic agent. • Clonidine and fluvoxamine may be effective for alcohol related dementias. • More research on “cognitive enhancers” in alcohol-related disorders are needed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-affective cognition</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol amnestic disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Korsakoff psychosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nootropics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol dependence</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcoholic organic brain syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive enhancers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcohol related dementia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neurocognition</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive deficits</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andersen, Kjeld</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, Anette Søgaard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goudriaan, Anneke E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Michel, Tanja Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Skøt, Lotte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, Dorthe Grüner</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mellentin, Angelina Isabella</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Ohashi, Nobuko ELSEVIER</subfield><subfield code="t">Norepinephrine Restores Inhibitory Tone of Spinal Lamina X Circuitry, thus Contributing to Analgesia Against Inflammatory Pain</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the International Behavioral Neuroscience Society</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007772211</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:125</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:608-626</subfield><subfield code="g">extent:19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.neubiorev.2021.02.038</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.90</subfield><subfield code="j">Neurologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">125</subfield><subfield code="j">2021</subfield><subfield code="h">608-626</subfield><subfield code="g">19</subfield></datafield></record></collection>
|
| score |
7.4016685 |